Botulinum toxin treatment for orofacial pain, bruxism or occlusal dysesthesia: (phase 2 patient study) Effect for the patients

Botulinum toxin treatment for orofacial pain, bruxism or occlusal dysesthesia: (phase 2 patient study) Effect for the patients - Botulinum toxin treatment for orofacial pain, bruxism or occlusal dysesthesia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009827

Enrollment

Registered

2013-04-01

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orofacial pain, bruxism, occlusal dysethesia

Interventions

Botulinum toxin 100U

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Out patients who will agree to enter this study. Over 20 years old. Male and female.

Exclusion criteria

Exclusion criteria: Subjects who have systematic problem

Design outcomes

Primary

Measure	Time frame
visual analogue scale data for subjective symptom	—

Countries

Japan

Contacts

Public ContactYoshizo Matsuka

Tokushima University Hospital Dentistry (Second prosthodontic)

matsuka@tokushima-u.ac.jp088-633-7350

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026